LIVN Q3 2025 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$358M+12.5% YoY

Gross Profit

$245M68.4% margin

Operating Income

$54M15.1% margin

Net Income

$27M7.5% margin

EPS (Diluted)

$0.49

QoQ Revenue Growth

+1.5%

Cash Flow

Operating Cash Flow

$85M

Free Cash Flow

$62M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$1.4B

Stockholders' Equity

$1.2B

Cash & Equivalents

$646M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$358M	$318M	+12.5%
Gross Profit	$245M	$225M	+8.7%
Operating Income	$54M	$36M	+51.6%
Net Income	$27M	$33M	-18.7%

Revenue Segments

Cardiopulmonary Segment

$203M58%

Neuromodulation Segment

$150M42%

Geographic Segments

UNITED STATES

$190M53%

Locations Excluding The United States And Europe

$100M28%

Europe

$68M19%